AKEBIA THERAPEUTICS, INC. Depreciation
AKEBIA THERAPEUTICS, INC. (AKBA) reported Depreciation of $913.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Operating Activities
us-gaap:Depreciation · last filed 2026-08-05
- AKEBIA THERAPEUTICS, INC. depreciation for the quarter ending 2026-06-30 was $585.00K, a 85.13% increase year-over-year.
- AKEBIA THERAPEUTICS, INC. depreciation for the quarter ending 2026-03-31 was $328.00K, a 4.46% increase year-over-year.
- AKEBIA THERAPEUTICS, INC. depreciation for the quarter ending 2025-12-31 was $321.00K, a 4.18% decline year-over-year.
- AKEBIA THERAPEUTICS, INC. depreciation for the quarter ending 2025-09-30 was $318.00K, a 12.40% decline year-over-year.
- AKEBIA THERAPEUTICS, INC. depreciation for fiscal 2025 was $1.27M, a 13.20% decline from fiscal 2024.
- AKEBIA THERAPEUTICS, INC. depreciation for fiscal 2024 was $1.46M, a 7.76% decline from fiscal 2023.
- AKEBIA THERAPEUTICS, INC. depreciation for fiscal 2023 was $1.58M, a 4.17% decline from fiscal 2022.
- AKEBIA THERAPEUTICS, INC. depreciation for fiscal 2022 was $1.65M, a 12.95% decline from fiscal 2021.
| Period end | Depreciation 3 month | Depreciation 3 month as first filed | Depreciation 6 month | Depreciation 6 month as first filed | Depreciation 9 month | Depreciation 9 month as first filed | Depreciation 12 month | Depreciation 12 month as first filed | Depreciation 85 month |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $585.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $913.00K 10-Q · filed 2026-08-05 | $1.23M derived: sum of 3 quarters · filed 2026-08-05 | $1.55M derived: sum of 4 quarters · filed 2026-08-05 | |||||
| 2026-03-31 | $328.00K 10-Q · filed 2026-05-07 | $649.00K derived: sum of 2 quarters · filed 2026-05-07 | $967.00K derived: sum of 3 quarters · filed 2026-05-07 | $1.28M derived: sum of 4 quarters · filed 2026-08-05 | |||||
| 2025-12-31 | $321.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $639.00K derived: sum of 2 quarters · filed 2026-02-26 | $955.00K derived: sum of 3 quarters · filed 2026-08-05 | $1.27M 10-K · filed 2026-02-26 | |||||
| 2025-09-30 | $318.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $634.00K derived: sum of 2 quarters · filed 2026-08-05 | $948.00K 10-Q · filed 2025-11-10 | $1.28M derived: sum of 4 quarters · filed 2026-08-05 | |||||
| 2025-06-30 | $316.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $630.00K 10-Q · filed 2026-08-05 | $965.00K derived: sum of 3 quarters · filed 2026-08-05 | $1.33M derived: sum of 4 quarters · filed 2026-08-05 | |||||
| 2025-03-31 | $314.00K 10-Q · filed 2026-05-07 | $649.00K derived: sum of 2 quarters · filed 2026-05-07 | $1.01M derived: sum of 3 quarters · filed 2026-05-07 | $1.41M derived: sum of 4 quarters · filed 2026-05-07 | |||||
| 2024-12-31 | $335.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $698.00K derived: sum of 2 quarters · filed 2026-02-26 | $1.10M derived: sum of 3 quarters · filed 2026-02-26 | $1.46M 10-K · filed 2026-02-26 | |||||
| 2024-09-30 | $363.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $763.00K derived: sum of 2 quarters · filed 2025-11-10 | $1.13M 10-Q · filed 2025-11-10 | $1.52M derived: sum of 4 quarters · filed 2026-02-26 | |||||
| 2024-06-30 | $400.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $764.00K 10-Q · filed 2025-08-07 | $1.16M derived: sum of 3 quarters · filed 2026-02-26 | $1.55M derived: sum of 4 quarters · filed 2026-02-26 | |||||
| 2024-03-31 | $364.00K 10-Q · filed 2025-05-08 | $758.00K derived: sum of 2 quarters · filed 2026-02-26 | $1.15M derived: sum of 3 quarters · filed 2026-02-26 | $1.55M derived: sum of 4 quarters · filed 2026-02-26 | |||||
| 2023-12-31 | $394.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $790.00K derived: sum of 2 quarters · filed 2026-02-26 | $1.19M derived: sum of 3 quarters · filed 2026-02-26 | $1.58M 10-K · filed 2026-02-26 | |||||
| 2023-09-30 | $396.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $793.00K derived: sum of 2 quarters · filed 2024-11-07 | $1.19M 10-Q · filed 2024-11-07 | $1.60M derived: sum of 4 quarters · filed 2024-11-07 | |||||
| 2023-06-30 | $397.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $795.00K 10-Q · filed 2024-08-08 | $1.20M derived: sum of 3 quarters · filed 2024-08-08 | ||||||
| 2023-03-31 | $398.00K 10-Q · filed 2024-05-09 | $806.00K derived: sum of 2 quarters · filed 2024-05-09 | |||||||
| 2022-12-31 | $408.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-14 | $1.65M 10-K · filed 2024-03-14 | $1.70M 10-K · filed 2023-03-10 | ||||||
| 2022-09-30 | $1.25M 10-Q · filed 2023-11-08 | ||||||||
| 2021-12-31 | $1.90M 10-K/A · filed 2023-08-28 | ||||||||
| 2020-12-31 | $500.00K derived: 10-K/A 12 month − 10-Q 9 month · filed 2023-08-28 | $1.00M derived: sum of 2 quarters · filed 2023-08-28 | $1.50M derived: sum of 3 quarters · filed 2023-08-28 | $2.10M 10-K/A · filed 2023-08-28 | |||||
| 2020-09-30 | $500.00K 10-Q · filed 2020-11-05 | $1.00M derived: sum of 2 quarters · filed 2020-11-05 | $1.60M 10-Q · filed 2020-11-05 | $2.00M derived: sum of 4 quarters · filed 2022-03-01 | |||||
| 2020-06-30 | $500.00K 10-Q · filed 2020-08-10 | $1.00M 10-Q · filed 2020-08-10 | $1.50M derived: sum of 3 quarters · filed 2022-03-01 | $2.10M derived: sum of 4 quarters · filed 2022-03-01 | |||||
| 2020-03-31 | $500.00K 10-Q · filed 2020-05-05 | $1.00M derived: sum of 2 quarters · filed 2022-03-01 | $1.60M derived: sum of 3 quarters · filed 2022-03-01 | $2.20M derived: sum of 4 quarters · filed 2022-03-01 | |||||
| 2019-12-31 | $500.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $1.10M derived: sum of 2 quarters · filed 2022-03-01 | $1.70M derived: sum of 3 quarters · filed 2022-03-01 | $2.20M 10-K · filed 2022-03-01 | |||||
| 2019-09-30 | $600.00K 10-Q · filed 2020-11-05 | $1.20M derived: sum of 2 quarters · filed 2020-11-05 | $1.70M 10-Q · filed 2020-11-05 | $1.90M derived: sum of 4 quarters · filed 2021-02-25 | |||||
| 2019-06-30 | $600.00K 10-Q · filed 2020-08-10 | $1.00M 10-Q · filed 2020-08-10 | $1.30M derived: sum of 3 quarters · filed 2021-02-25 | $1.50M derived: sum of 4 quarters · filed 2021-02-25 | |||||
| 2019-03-31 | $400.00K 10-Q · filed 2020-05-05 | $700.00K derived: sum of 2 quarters · filed 2021-02-25 | $900.00K derived: sum of 3 quarters · filed 2021-02-25 | $1.10M derived: sum of 4 quarters · filed 2021-02-25 | |||||
| 2018-12-31 | $300.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $500.00K derived: sum of 2 quarters · filed 2021-02-25 | $700.00K derived: sum of 3 quarters · filed 2021-02-25 | $900.00K 10-K · filed 2021-02-25 | |||||
| 2018-09-30 | $200.00K 10-Q · filed 2019-11-12 | $400.00K derived: sum of 2 quarters · filed 2019-11-12 | $600.00K 10-Q · filed 2019-11-12 | $800.00K derived: sum of 4 quarters · filed 2020-03-12 | |||||
| 2018-06-30 | $200.00K 10-Q · filed 2019-08-08 | $400.00K 10-Q · filed 2019-08-08 | $600.00K derived: sum of 3 quarters · filed 2020-03-12 | $800.00K derived: sum of 4 quarters · filed 2020-03-12 | |||||
| 2018-03-31 | $200.00K 10-Q · filed 2019-05-09 | $400.00K derived: sum of 2 quarters · filed 2020-03-12 | $600.00K derived: sum of 3 quarters · filed 2020-03-12 | $700.00K derived: sum of 4 quarters · filed 2020-03-12 | |||||
| 2017-12-31 | $200.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-12 | $400.00K derived: sum of 2 quarters · filed 2020-03-12 | $500.00K derived: sum of 3 quarters · filed 2020-03-12 | $600.00K 10-K · filed 2020-03-12 | $616.00K 10-K · filed 2018-03-12 | ||||
| 2017-09-30 | $200.00K 10-Q · filed 2018-11-08 | $300.00K derived: sum of 2 quarters · filed 2018-11-08 | $400.00K 10-Q · filed 2018-11-08 | $500.00K derived: sum of 4 quarters · filed 2019-03-26 | |||||
| 2017-06-30 | $100.00K 10-Q · filed 2018-08-08 | $300.00K 10-Q · filed 2018-08-08 | $300.00K derived: sum of 3 quarters · filed 2019-03-26 | $400.00K derived: sum of 4 quarters · filed 2019-03-26 | |||||
| 2017-03-31 | $100.00K 10-Q · filed 2018-05-09 | $200.00K derived: sum of 2 quarters · filed 2019-03-26 | $300.00K derived: sum of 3 quarters · filed 2019-03-26 | $346.00K derived: sum of 4 quarters · filed 2019-03-26 | |||||
| 2016-12-31 | $100.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-26 | $200.00K derived: sum of 2 quarters · filed 2019-03-26 | $246.00K derived: sum of 3 quarters · filed 2019-03-26 | $300.00K 10-K · filed 2019-03-26 | $295.00K 10-K · filed 2017-03-06 | ||||
| 2016-09-30 | $100.00K 10-Q · filed 2017-11-08 | $93.00K 10-Q · filed 2016-11-09 | $146.00K derived: sum of 2 quarters · filed 2017-11-08 | $200.00K 10-Q · filed 2017-11-08 | $171.00K 10-Q · filed 2016-11-09 | $189.00K derived: sum of 4 quarters · filed 2018-03-12 | |||
| 2016-06-30 | $46.00K 10-Q · filed 2017-08-08 | $100.00K 10-Q · filed 2017-08-08 | $78.00K 10-Q · filed 2016-08-08 | $89.00K derived: sum of 3 quarters · filed 2018-03-12 | $124.00K derived: sum of 4 quarters · filed 2018-03-12 | ||||
| 2016-03-31 | $32.00K 10-Q · filed 2017-05-09 | $43.00K derived: sum of 2 quarters · filed 2018-03-12 | $78.00K derived: sum of 3 quarters · filed 2018-03-12 | $110.00K derived: sum of 4 quarters · filed 2018-03-12 | |||||
| 2015-12-31 | $11.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-12 | $46.00K derived: sum of 2 quarters · filed 2018-03-12 | $78.00K derived: sum of 3 quarters · filed 2018-03-12 | $96.00K 10-K · filed 2018-03-12 | |||||
| 2015-09-30 | $35.00K 10-Q · filed 2016-11-09 | $67.00K derived: sum of 2 quarters · filed 2016-11-09 | $85.00K 10-Q · filed 2016-11-09 | $102.00K derived: sum of 4 quarters · filed 2017-03-06 | |||||
| 2015-06-30 | $32.00K 10-Q · filed 2016-08-08 | $50.00K 10-Q · filed 2016-08-08 | $67.00K derived: sum of 3 quarters · filed 2017-03-06 | $80.00K derived: sum of 4 quarters · filed 2017-03-06 | |||||
| 2015-03-31 | $19.00K 10-Q · filed 2016-05-05 | $35.00K derived: sum of 2 quarters · filed 2017-03-06 | $48.00K derived: sum of 3 quarters · filed 2017-03-06 | $59.97K derived: sum of 4 quarters · filed 2017-03-06 | |||||
| 2014-12-31 | $16.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-06 | $29.00K derived: sum of 2 quarters · filed 2017-03-06 | $40.97K derived: sum of 3 quarters · filed 2017-03-06 | $49.00K 10-K · filed 2017-03-06 | $49.36K 10-K · filed 2015-03-04 | ||||
| 2014-09-30 | $13.00K 10-Q · filed 2015-11-09 | $13.19K 10-Q · filed 2014-11-10 | $24.97K derived: sum of 2 quarters · filed 2015-11-09 | $33.00K 10-Q · filed 2015-11-09 | $33.28K 10-Q · filed 2014-11-10 | $33.95K derived: sum of 4 quarters · filed 2016-03-14 | |||
| 2014-06-30 | $11.97K 10-Q · filed 2014-08-11 | $20.00K 10-Q · filed 2015-08-11 | $20.09K 10-Q · filed 2014-08-11 | $20.95K derived: sum of 3 quarters · filed 2016-03-14 | $20.97K derived: sum of 4 quarters · filed 2016-03-14 | ||||
| 2014-03-31 | $8.00K 10-Q · filed 2015-05-11 | $8.12K 10-Q · filed 2014-05-12 | $8.97K derived: sum of 2 quarters · filed 2016-03-14 | $9.00K derived: sum of 3 quarters · filed 2016-03-14 | $9.00K derived: sum of 4 quarters · filed 2016-03-14 | $99.54K 10-Q · filed 2014-05-12 | |||
| 2013-12-31 | $974.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-14 | $1.00K derived: sum of 2 quarters · filed 2016-03-14 | $1.00K derived: sum of 3 quarters · filed 2016-03-14 | $1.00K 10-K · filed 2016-03-14 | $1.28K 10-K · filed 2015-03-04 | ||||
| 2013-09-30 | $26.00 10-Q · filed 2014-11-10 | $26.00 derived: sum of 2 quarters · filed 2014-11-10 | $26.00 10-Q · filed 2014-11-10 | ||||||
| 2013-06-30 | $0.00 10-Q · filed 2014-08-11 | $0.00 10-Q · filed 2014-08-11 | |||||||
| 2013-03-31 | $0.00 10-Q · filed 2014-05-12 | ||||||||
| 2012-12-31 | $0.00 10-K · filed 2015-03-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lyell Immunopharma, Inc. (LYEL) | United States | $0.248B | -1.32 |
| Pyxis Oncology, Inc. (PYXS) | United States | $0.244B | |
| Greenwich LifeSciences, Inc. (GLSI) | United States | $0.267B | -15.02 |
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Mereo BioPharma Group plc (MREO) | $0.269B | -9.41 | |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |